2024
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
Vitale A, Trapani S, Russo F, Miele L, Baroni G, Marchesini G, Burra P, Ottoveggio M, Romagnoli R, Martini S, De Simone P, Carrai P, Cescon M, Morelli M, De Carlis L, Belli L, Gruttadauria S, Volpes R, Colledan M, Fagiuoli S, Di Benedetto F, De Maria N, Rossi G, Caccamo L, Donato F, Vennarecci G, Di Costanzo G, Vivarelli M, Carraro A, Sacerdoti D, Ettorre G, Giannelli V, Agnes S, Gasbarrini A, Rossi M, Corradini S, Mazzaferro V, Bhoori S, Manzia T, Lenci I, Zamboni F, Mameli L, Baccarani U, Toniutto P, Lupo L, Tandoi F, Rendina M, Andorno E, Giannini E, Spada M, Billato I, Marchini A, Romano P, Brancaccio G, D’Amico F, Ricci A, Cardillo M, Cillo U, del Fegato . A, . S, Trapianti C. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study. JHEP Reports 2024, 6: 101147. PMID: 39282226, PMCID: PMC11399673, DOI: 10.1016/j.jhepr.2024.101147.Peer-Reviewed Original ResearchSurvival benefit of patientsTransplant survival benefitHepatocellular carcinomaLiver transplantationLiver diseaseIncreased waitlist mortalityPatient survivalBenefit of patientsSteatotic liver diseaseEnd-stage chronic liver diseaseAbstractText Label="Background &Waiting listImprove patient survivalWaitlist mortalityLiver transplant indicationsChronic liver diseaseAlcoholic liver diseaseRisk of deathWaiting list mortalityAbstractText Label="ImpactPrognostic featuresTransplant eligibility criteriaSurvival benefitTransplant indicationAdult patients
2022
Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson’s disease: Protocol of the mixed method, cyclic ActiveAgeing study
Torrado JC, Husebo BS, Allore HG, Erdal A, Fæø SE, Reithe H, Førsund E, Tzoulis C, Patrascu M. Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson’s disease: Protocol of the mixed method, cyclic ActiveAgeing study. PLOS ONE 2022, 17: e0275747. PMID: 36240173, PMCID: PMC9565381, DOI: 10.1371/journal.pone.0275747.Peer-Reviewed Original ResearchConceptsREM Sleep Behavior Disorder Screening QuestionnaireUnified Parkinson's Disease Rating ScaleDisease Rating ScaleGeriatric Depression ScaleApathy Evaluation ScaleParkinson's diseaseOlder adultsGeriatric Anxiety InventoryParkinson's Disease Rating ScaleClinical assessment scalesMontreal Cognitive AssessmentNew outcome measureQuality of lifeGlobal public healthHealthy older adultsClinical trialsOutcome measuresDepression ScaleLifestyle changesScreening QuestionnaireWaiting listFunctional limitationsSymptom evolutionNeurological disordersAssessment Scale
2020
Survival on the Heart Transplant Waiting List
Bakhtiyar SS, Godfrey EL, Ahmed S, Lamba H, Morgan J, Loor G, Civitello A, Cheema FH, Etheridge WB, Goss J, Rana A. Survival on the Heart Transplant Waiting List. JAMA Cardiology 2020, 5: 1227-1235. PMID: 32785619, PMCID: PMC7675100, DOI: 10.1001/jamacardio.2020.2795.Peer-Reviewed Original ResearchConceptsVentricular assist deviceHeart transplant waiting listList survivalTransplant waiting listWaiting listMultivariable Cox proportional hazards regression analysisCox proportional hazards regression analysisProportional hazards regression analysisHeart transplantation waiting listAdjusted survival analysisHazards regression analysisTransplantation waiting listWait-listed candidatesCandidate risk factorsHeart transplantationList mortalityUNOS databaseClinical improvementHeart transplantPrimary outcomeAdjusted analysisSurvival outcomesKaplan-MeierPatient groupUnited NetworkEvaluation of Case Volumes of a Heart Transplant Program and Short-term Outcomes After Changes in the United Network for Organ Sharing Donor Heart Allocation System
Mori M, Wilson L, Ali A, Ahmad T, Anwer M, Jacoby D, Geirsson A, Krumholz HM. Evaluation of Case Volumes of a Heart Transplant Program and Short-term Outcomes After Changes in the United Network for Organ Sharing Donor Heart Allocation System. JAMA Network Open 2020, 3: e2017513. PMID: 32945877, PMCID: PMC7501535, DOI: 10.1001/jamanetworkopen.2020.17513.Peer-Reviewed Original ResearchConceptsYale-New Haven HospitalHeart transplant programShort-term outcomesHeart transplantHeart transplant volumeNew Haven HospitalDonor heartsPatient selectionRecipient selectionTransplant programsTransplant volumeWaiting listCase volumeDonor heart allocation systemPre-post cohort studyConservative patient selectionUnused donor heartsHeart allocation systemHigher median numberCirculatory assist devicesCohort studyPatient characteristicsMore patientsSingle centerCenter volumeTemporal trends and outcomes of patients waiting on left ventricular assist devices and inotropes for heart transplantation
Briasoulis A, Adegbala O, Akintoye E, Alvarez P. Temporal trends and outcomes of patients waiting on left ventricular assist devices and inotropes for heart transplantation. Clinical Transplantation 2020, 34: e13857. PMID: 32167606, DOI: 10.1111/ctr.13857.Peer-Reviewed Original ResearchConceptsLeft ventricular assist deviceRight ventricular assist deviceVentricular assist deviceOutcomes of patientsTime of listingTime of transplantationHeart transplantationAssist deviceOrgan Sharing registryTerms of survivalStatus 1AInotropic therapyLVAD recipientsUnited NetworkWorse outcomesInotropesHigh riskWaiting listPatientsTransplantationLower ratesOutcomesTemporal trendsConfoundersRegistryThe Role of the General Nephrologist in Evaluating Patients for Kidney Transplantation: Core Curriculum 2020
Virmani S, Asch WS. The Role of the General Nephrologist in Evaluating Patients for Kidney Transplantation: Core Curriculum 2020. American Journal Of Kidney Diseases 2020, 76: 567-579. PMID: 32199707, DOI: 10.1053/j.ajkd.2020.01.001.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsGeneral nephrologistKidney transplantationTransplantation centersKidney transplant waiting listHigher Body Mass IndexCore Curriculum 2020Body mass indexTransplant waiting listLife-saving therapyAllograft outcomesMost patientsPrior malignancyPatient factorsMass indexReplacement therapyKidney failureCardiovascular healthOptimal patientNew patientsWaiting listPreferred modalityPatientsNephrologistsTransplantationRecipient evaluationThe impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation
Briasoulis A, Akintoye E, Inampudi C, Hammoud A, Alvarez P. The impact of insurance type on listing status and wait‐list mortality of patients with left ventricular assist devices as bridge to transplantation. ESC Heart Failure 2020, 7: 804-810. PMID: 32135039, PMCID: PMC7261523, DOI: 10.1002/ehf2.12655.Peer-Reviewed Original ResearchConceptsLeft ventricular assist deviceInsurance typeVentricular assist deviceTime of listingWaiting listAssist deviceHeart transplantation candidatesOrgan Sharing registryWait-list mortalityRisk regression analysisDifferent insurance typesAdequate health insurance coverageHealth insurance coverageStatus 1APublic health insuranceCumulative incidenceTransplantation candidatesTransplantation ratesUnited NetworkPost-HTMA patientsType of insurancePatientsMortalityCumulative mortality
2019
The Impact of Insurance Type on Listing Status and Mortality on the Waiting List: Insights from the United Network for Organ Sharing (UNOS)
Briasoulis A, Akintoye E, Duque E, Inampudi C, Bhama J, Alvarez P. The Impact of Insurance Type on Listing Status and Mortality on the Waiting List: Insights from the United Network for Organ Sharing (UNOS). The Journal Of Heart And Lung Transplantation 2019, 38: s399-s400. DOI: 10.1016/j.healun.2019.01.1017.Peer-Reviewed Original ResearchInsurance typeTime of listingWaiting listUnited NetworkHeart transplantation candidatesOrgan Sharing registryProportion of patientsPatient's clinical improvementRisk regression analysisDifferent insurance typesAdequate health insurance coverageHealth insurance coverageStatus 1APublic health insuranceClinical improvementCumulative incidenceTransplant listTransplantation candidatesMethods PatientsTransplantation ratesPost-HTMA patientsOrgan SharingType of insuranceFrequent reason
2018
Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List
Miles CD, Westphal S, Liapakis A, Formica R. Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List. Current Transplantation Reports 2018, 5: 1-6. PMID: 29564203, PMCID: PMC5843696, DOI: 10.1007/s40472-018-0175-z.Peer-Reviewed Original ResearchSimultaneous liver-kidney transplantKidney waitlistEnd-stage liver diseaseKidney transplant waiting listHigh MELD candidatesLiver-kidney transplantPersistent renal failureLiver transplant patientsLiver transplant candidatesNon-alcoholic steatohepatitisTransplant waiting listConcurrent renal insufficiencyLiver recipientsLiver transplantRenal insufficiencyTransplant patientsRenal failureTransplant candidatesLiver diseaseKidney failureLiver patientsWaiting listEligibility criteriaOrgan procurementTransplantation Network
2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
Belli LS, Duvoux C, Berenguer M, Berg T, Coilly A, Colle I, Fagiuoli S, Khoo S, Pageaux GP, Puoti M, Samuel D, Strazzabosco M. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients. Journal Of Hepatology 2017, 67: 585-602. PMID: 28323126, DOI: 10.1016/j.jhep.2017.03.006.Peer-Reviewed Original ResearchConceptsLiver transplantationHCV infectionConsensus statementUse of DAAsLiver transplant candidatesLiver transplant recipientsSevere renal failureRemarkable clinical improvementTransplant recipientsClinical improvementLT candidatesRenal failureTransplant candidatesDisease recurrenceNative liverUnusual complicationTransplant fieldDrug interactionsHCV- graftsWaiting listAntiviral agentsRecipientsHCVPatientsGraft
2016
Interim Buprenorphine vs. Waiting List for Opioid Dependence
Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. New England Journal Of Medicine 2016, 375: 2504-2505. PMID: 28002704, PMCID: PMC5373028, DOI: 10.1056/nejmc1610047.Peer-Reviewed Original ResearchLiver Transplantation: An Overview
Kim J, Hong J. Liver Transplantation: An Overview. 2016, 599-619. DOI: 10.1007/978-3-319-30103-7_36.Peer-Reviewed Original ResearchOrthotopic liver transplantationLiver transplantationGraft failurePrimary nonfunctionRecurrence of primary liver diseaseAbsence of systemic metastasisOrthotopic liver transplant recipientsPatient’s MELD scorePractice of liver transplantationDeceased donor liver graftsIrreversible liver failureBile duct cancerPrimary liver diseaseLiver transplant waiting listPatient survival outcomesDonor liver graftsWaiting listHepatic allograft functionTransplant waiting listImmunosuppressive regimensSystemic metastasesAllograft functionChronic rejectionLife-saving treatmentSurvival outcomesLiver-allocation policies for patients affected by HCC in Europe
De Carlis L, Di Sandro S, Centonze L, Lauterio A, Buscemi V, De Carlis R, Ferla F, Sguinzi R, Okolicsanyi S, Belli L, Strazzabosco M. Liver-allocation policies for patients affected by HCC in Europe. Current Transplantation Reports 2016, 3: 313-318. PMID: 28473952, PMCID: PMC5410888, DOI: 10.1007/s40472-016-0117-6.Peer-Reviewed Original ResearchLiver allocation policyWaiting listCentro Nazionale TrapiantiOrgan SharingDeceased donor liver transplantLong-term survival ratesTransplant waiting listOrgan allocation systemOrgan allocation policyEtablissement français des GreffesLiver graftsLiver transplantLiver diseaseUnited NetworkNHS BloodSurvival rateDisease changesPatientsPotential Pediatric Organ Donors After Cardiac Death
Pregernig A, Karam O. Potential Pediatric Organ Donors After Cardiac Death. Transplantation Proceedings 2016, 48: 2588-2591. PMID: 27788786, DOI: 10.1016/j.transproceed.2016.06.049.Peer-Reviewed Original ResearchConceptsWithdrawal of careOrgan donorsAgonal timeMaximal resuscitationCardiac deathPediatric populationNeonatal intensive care unitOrgan donationBrain-dead childrenIntensive care unitOrgan donor poolTransplant waiting listPediatric organ donorPotential organ donorsOrgan donation programsMedical contraindicationsCare unitRetrospective studyDonor poolWaiting listDonation programDonor populationCareChildrenResuscitationPredicting Outcomes on the Liver Transplant Waiting List in the United States
Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States. Transplantation 2016, 100: 2153-2159. PMID: 27490411, PMCID: PMC5369025, DOI: 10.1097/tp.0000000000001384.Peer-Reviewed Original ResearchConceptsDonation service areaLiver transplantWaiting listEnd-stage liver disease (MELD) scoreLiver transplant waiting listTransplant Recipients databaseLiver Disease scoreMELD exception pointsTransplant waiting listAvailability of organsTransplant probabilityRecipients databasePatient characteristicsScientific RegistryTransplant programsUS adultsDisease scorePredicting OutcomeException pointsTransplantBlood typeOutcomesOngoing disparitiesCorresponding percentilesOnline calculatorOrgan Transplantation for Individuals with Neurodevelopmental Disorders
Overby K, Fins J. Organ Transplantation for Individuals with Neurodevelopmental Disorders. Cambridge Quarterly Of Healthcare Ethics 2016, 25: 272-281. PMID: 26957452, DOI: 10.1017/s0963180115000572.Peer-Reviewed Original ResearchConceptsPhysician referralRegional Transplant CenterHealthcare professionalsHealthcare systemHeart-lung transplantationNeurodevelopmental disordersFunctional impairmentWaiting listHealthcareProvision of accommodationMedical managementMedical needOrgan transplantationTransplant centersDown syndromeNational levelTransplantationOvert discriminationIndividualsAccess problemsReferralPhysiciansProfessionalsContemporary challengesDisorders
2015
Patients with Psychotic Disorders in Solid-Organ Transplant
Zimbrean P, Emre S. Patients with Psychotic Disorders in Solid-Organ Transplant. Progress In Transplantation 2015, 25: 289-296. PMID: 26645920, DOI: 10.7182/pit2015296.Peer-Reviewed Original ResearchConceptsPsychotic disordersOrgan transplantsTransplant candidatesComorbid conditionsMedical comorbid conditionsOutcomes of patientsType of transplantAssociated comorbid conditionsNumber of hospitalizationsSeverity of psychosisToxic effectsPosttransplant variablesTransplant recipientsAbsolute contraindicationClinical courseOrgan failureMedication adherenceOrgan recipientsPsychiatric hospitalizationPsychotic episodeWaiting listPatientsPsychotic patientsTransplantDescriptive studyLife on a waiting list: How do people experience and cope with delayed access to a community mental health center?
Biringer E, Sundfør B, Davidson L, Hartveit M, Borg M. Life on a waiting list: How do people experience and cope with delayed access to a community mental health center? Scandinavian Psychologist 2015, 2 DOI: 10.15714/scandpsychol.2.e6.Peer-Reviewed Original ResearchConcurrent Alcohol and Tobacco Treatment: Effect on Daily Process Measures of Alcohol Relapse Risk
Cooney NL, Litt MD, Sevarino KA, Levy L, Kranitz LS, Sackler H, Cooney JL. Concurrent Alcohol and Tobacco Treatment: Effect on Daily Process Measures of Alcohol Relapse Risk. Journal Of Consulting And Clinical Psychology 2015, 83: 346-358. PMID: 25622198, PMCID: PMC4380705, DOI: 10.1037/a0038633.Peer-Reviewed Original ResearchConceptsSmoking cessation interventionSmoking treatmentCessation interventionsSmoking abstinenceProcess measuresAlcohol treatmentOutpatient alcohol treatment programAlcohol-dependent smokersDaily smoking abstinenceAlcohol relapse riskOutpatient alcohol treatmentLow alcohol consumptionAlcohol treatment programsDependent smokersRelapse riskAlcohol abstinenceWaiting listInteractive voice response systemSmoking outcomesAlcohol consumptionCSC participantsVoice response systemIVR assessmentsTreatment programDaily assessment“Bureaucracy & Beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine
Bojko MJ, Mazhnaya A, Makarenko I, Marcus R, Dvoriak S, Islam Z, Altice FL. “Bureaucracy & Beliefs”: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine. Drugs Education Prevention And Policy 2015, 22: 255-262. PMID: 27087758, PMCID: PMC4831711, DOI: 10.3109/09687637.2015.1016397.Peer-Reviewed Original ResearchOpioid substitution therapySubstitution therapySide effectsEvidence-based HIV prevention strategiesOpioid-dependent PWIDHIV prevention strategiesMulti-level barriersImplementation science projectHIV preventionMethadone clientsTreatment accessWaiting listPWIDPrevention strategiesTreatment attitudesSocial marketing campaignFree treatmentTreatment slotsTreatmentPublic healthTherapyFocus group discussionsDrugsStructural barriersParticipants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply